DR REDDY SLABORATORIES INC — Metoprolol Importer Profile
Pharmaceutical Importer · #15 buyer for Metoprolol · $2.2M import value · 50 shipments · UNITED STATES · DGFT Verified
DR REDDY SLABORATORIES INC is the #15 importer of Metoprolol from India with $2.2M in import value and 50 verified shipments. DR REDDY SLABORATORIES INC holds a 0.3% market share in Metoprolol imports based in UNITED STATES. The company sources from 1 verified supplier across 50 formulations shipped to 1 country. Overall, DR REDDY SLABORATORIES INC imports 2 pharmaceutical products worth $5.8M across 2 therapeutic categories.
DR REDDY SLABORATORIES INC — Metoprolol Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Metoprolol to DR REDDY SLABORATORIES INC?
Verified from 50 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| DR REDDYS LABORATORIES LIMITED | $2.2M | 50 | 100.0% |
DR REDDY SLABORATORIES INC sources Metoprolol from 1 verified Indian supplier based on 50 customs records. The primary supplier is DR REDDYS LABORATORIES LIMITED accounting for 100.0% of imports.
Where Does DR REDDY SLABORATORIES INC Import Metoprolol To?
Destination countries from 50 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $2.2M | 50 | 100.0% |
DR REDDY SLABORATORIES INC imports Metoprolol to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $2.2M.
What Metoprolol Formulations Does DR REDDY SLABORATORIES INC Import?
| Formulation | Value | Shipments |
|---|---|---|
| 300011463 METOPROLOL SUCCINATE EXTENDEDRELEASE TABLETS USP 50MG 500S 6512*500=3256000 | $50.0K | 1 |
| 300011471METOPROLOL SUCCINATE EXTENDED-RELEASE TABLETS USP 25MG L00S 59832*100=5983200 | $50.0K | 1 |
| 300011449 METOPROLOL SUCCINATE EXTENDEDRELEASE TABLETS USP 100MG 500S 14834 X500=7417000 NOS | $50.0K | 1 |
| METOPROLOL SUCCINATE EXTENDED-RELEASE TABLETS USP 50MG500'S13832 X 500S PACKS= 6916000 NOS | $50.0K | 1 |
| METOPROLOL SUCCINATE EXTENDED-RELEASE TABLETS USP 50MG 500'S 6456 X 500S PACKS=3228000 NOS | $50.0K | 1 |
| 300011449 METOPROLOL SUCCINATE EXTENDEDRELEASE TABLETS USP 100MG 500S 6596 SUX 500=32,98,000 NOS | $50.0K | 1 |
| 300011445 METOPROLOL SUCCINATE EXTENDEDRELEASE TABLETS USP 200MG 100S 12397 SUX 100=1239700 NOS | $50.0K | 1 |
| 300011464 METOPROLOL SUCCINATE EXTENDEDRELEASE TABLETS USP 50MG 100S 47631 SUX 100=4763100 NOS | $50.0K | 1 |
| 300011464 METOPROLOL SUCCINATE EXTENDEDRELEASE TABLETS USP 50MG 100S 34920 SUX 100=3492000 NOS | $50.0K | 1 |
| 300011463 METOPROLOL SUCCINATE EXTENDEDRELEASE TABLETS USP 50MG 500S 19034 SUX 500=95,17,000 NOS | $50.0K | 1 |
DR REDDY SLABORATORIES INC imports 50 distinct Metoprolol formulations from India. The top formulation is 300011463 METOPROLOL SUCCINATE EXTENDEDRELEASE TABLETS USP 5 with 1 shipments worth $50.0K.
Regulatory Requirements: Importing Metoprolol into United States
What DR REDDY SLABORATORIES INC and other importers must comply with to import Metoprolol from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Metoprolol
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Metoprolol from India and How Much Does DR REDDY SLABORATORIES INC Import?
India exported $96.9M worth of Metoprolol through 10,118 shipments from 306 suppliers to 118 countries, serving 949 buyers globally. DR REDDY SLABORATORIES INC imports $2.2M of this total, accounting for 0.3% of India's Metoprolol exports with 50 shipments from UNITED STATES. This is verified from 50 customs shipment records covering 50 distinct formulations.
What Is the Average Order Value for DR REDDY SLABORATORIES INC's Metoprolol Imports?
DR REDDY SLABORATORIES INC's average Metoprolol order value is $44.5K per consignment, based on 50 shipments totaling $2.2M. DR REDDY SLABORATORIES INC is based in UNITED STATES and ranks #15 among all Metoprolol importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Metoprolol to DR REDDY SLABORATORIES INC?
DR REDDY SLABORATORIES INC sources Metoprolol from 1 verified Indian supplier: DR REDDYS LABORATORIES LIMITED ($2.2M, 100.0%). This is based on 50 customs records.
How Does DR REDDY SLABORATORIES INC Compare to Other Metoprolol Importers?
DR REDDY SLABORATORIES INC ranks #15 among 949 Metoprolol importers from India with a 0.3% market share. The top 3 importers are EVERSANA LIFE SCIENCES SERVICES LLC ($16.3M), CIPLA USA INC UPS SUPPLY CHAIN SOLU ($12.6M), DR. REDDYS LABORATORIES, INC ($11.1M). DR REDDY SLABORATORIES INC processed 50 shipments from UNITED STATES.
About DR REDDY SLABORATORIES INC
DR REDDY SLABORATORIES INC imports 2 products worth $5.8M. Beyond Metoprolol, top products include Diclofenac. View the complete DR REDDY SLABORATORIES INC profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Metoprolol — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Metoprolol shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: DR REDDY SLABORATORIES INC matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as DR REDDY SLABORATORIES INC's capped import value divided by total capped export value for Metoprolol across all Indian exporters.
- 5.Verified Records: This page is backed by 50 individual customs records matching DR REDDY SLABORATORIES INC importing Metoprolol, covering 50 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 118+ countries, 949+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Metoprolol Import Data for DR REDDY SLABORATORIES INC
Access order-level details, pricing data, supplier connections, and competitive analysis for DR REDDY SLABORATORIES INC's Metoprolol imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
DR REDDY SLABORATORIES INC
Full Company Profile →
2 products · $5.8M total trade · 2 categories
DR REDDY SLABORATORIES INC × Metoprolol
Verified from customs records
Company Overview
Top Products by DR REDDY SLABORATORIES INC
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for DR REDDY SLABORATORIES INC.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Metoprolol. For current order-level data, contact TransData Nexus.